Catalyst
Slingshot members are tracking this event:
Phase 3 HEPLISAV-B Trial Data to Be Presented at NFID's Annual Conference on Vaccine Research, Monday April 18th in Baltimore
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| DVAX | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 18, 2016
Occurred Source:
http://investors.dynavax.com/releasedetail.cfm?releaseid=965615
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3 Heplisav-b, Nfid, Vaccine Research
